Showing results (171-180 of 379) with videos related to

Sort By:
Pageof 38
Chest|November 25, 2018
Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired PneumoniaAdrian Ceccato, Catia Cilloniz, Ignacio Martin-Loeches, et al.
Annals of Intensive Care|February 22, 2017
Epidemiology of sepsis in Catalonia: analysis of incidence and outcomes in a European settingJuan Carlos Yébenes, Juan Carlos Ruiz-Rodriguez, Ricard Ferrer, et al.
Intensive Care Medicine|February 17, 2018
Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)Jean-Louis Vincent, Jean-Yves Lefrant, Katarzyna Kotfis, et al.
Intensive Care Medicine Experimental|March 10, 2026
Clinical practice in using corticosteroids and adjunctive sepsis therapies at the bedside among European ICUs: an ESICM-endorsed surveySascha David, Marc Leone, Massimo Girardis, et al.
Chest|August 7, 2010
Impact of obesity in patients infected with 2009 influenza A(H1N1)Emili Díaz, Alejandro Rodríguez, Ignacio Martin-Loeches, et al.
Chest|May 10, 2017
Decision-Making on Withholding or Withdrawing Life Support in the ICU: A Worldwide PerspectiveSuzana M Lobo, Flávio H B De Simoni, Stephan M Jakob, et al.
Infection, Disease & Health|August 19, 2024
Prediction of multidrug-resistant bacteria (MDR) hospital-acquired infection (HAI) and colonisation: A systematic reviewLeila Figueiredo Dantas, Igor Tona Peres, Bianca Brandão de Paula Antunes, et al.
Critical Care Medicine|March 17, 2021
Checklist for Early Recognition and Treatment of Acute Illness and Injury: An Exploratory Multicenter International Quality-Improvement Study in the ICUs With Variable ResourcesMarija Vukoja, Yue Dong, Neill K J Adhikari, et al.
Expert Opinion on Drug Delivery|October 19, 2017
In vitro evaluation of aerosol delivery of aztreonam lysine (AZLI): an adult mechanical ventilation modelAlejandro Rodríguez, María Cabrera, Luis F Reyes, et al.
Annals of Intensive Care|February 11, 2023
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trialIgnacio Martin-Loeches, Andrew F Shorr, Richard G Wunderink, et al.
Pageof 38